228 related articles for article (PubMed ID: 24869763)
1. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression.
Von Visger JR; Gunay Y; Andreoni KA; Bhatt UY; Nori US; Pesavento TE; Elkhammas EA; Winters HA; Nadasdy T; Singh N
Clin Transplant; 2014 Aug; 28(8):845-54. PubMed ID: 24869763
[TBL] [Abstract][Full Text] [Related]
2. Recurrent IgA nephropathy after renal transplantation and steroid withdrawal.
Di Vico MC; Messina M; Fop F; Barreca A; Segoloni GP; Biancone L
Clin Transplant; 2018 Apr; 32(4):e13207. PubMed ID: 29345747
[TBL] [Abstract][Full Text] [Related]
3. IgA nephropathy recurs early in the graft when assessed by protocol biopsy.
Ortiz F; Gelpi R; Koskinen P; Manonelles A; Räisänen-Sokolowski A; Carrera M; Honkanen E; Grinyó JM; Cruzado JM
Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy.
Sato Y; Ishida H; Shimizu T; Tanabe K
Transpl Immunol; 2014 Jan; 30(1):12-7. PubMed ID: 24246415
[TBL] [Abstract][Full Text] [Related]
5. Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents.
Avasare RS; Rosenstiel PE; Zaky ZS; Tsapepas DS; Appel GB; Markowitz GS; Bomback AS; Canetta PA
Am J Nephrol; 2017; 45(2):99-106. PubMed ID: 28056461
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of kidney transplantation in patients with IgA nephropathy based on induction: A UNOS data analysis.
Aydin-Ghormoz EA; Perlmutter J; Koizumi N; Ortiz J; Faddoul G
Clin Transplant; 2024 Jan; 38(1):e15225. PubMed ID: 38127110
[TBL] [Abstract][Full Text] [Related]
7. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.
Moroni G; Longhi S; Quaglini S; Gallelli B; Banfi G; Montagnino G; Messa P
Nephrol Dial Transplant; 2013 May; 28(5):1305-14. PubMed ID: 23229925
[TBL] [Abstract][Full Text] [Related]
8. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy.
Han SS; Huh W; Park SK; Ahn C; Han JS; Kim S; Kim YS
Transpl Int; 2010 Feb; 23(2):169-75. PubMed ID: 19761553
[TBL] [Abstract][Full Text] [Related]
9. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
[TBL] [Abstract][Full Text] [Related]
10. Favorable outcome of renal transplantation in patients with IgA nephropathy.
Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.
Leeaphorn N; Garg N; Khankin EV; Cardarelli F; Pavlakis M
Transpl Int; 2018 Feb; 31(2):175-186. PubMed ID: 28926143
[TBL] [Abstract][Full Text] [Related]
12. Impact of Induction Immunosuppression on the Recurrence of Primary IgA Nephropathy.
Lee KW; Kim KS; Lee JS; Yoo H; Kim K; Park JB; Kwon GY; Kim SJ
Transplant Proc; 2019 Jun; 51(5):1491-1495. PubMed ID: 31010698
[TBL] [Abstract][Full Text] [Related]
13. Clinical importance of the updated Oxford classification in allograft IgA nephropathy.
Park S; Go H; Baek CH; Kim YH; Kim YC; Yang SH; Lee JP; Min SI; Ha J; Song EY; Kim YS; Park SK; Lee H; Moon KC
Am J Transplant; 2019 Oct; 19(10):2855-2864. PubMed ID: 31017369
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
Namba Y; Oka K; Moriyama T; Ichimaru N; Kyo M; Kokado Y; Ito T; Imai E; Aozasa K; Okuyama A; Takahara S
Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321
[TBL] [Abstract][Full Text] [Related]
15. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.
Chandrakantan A; Ratanapanichkich P; Said M; Barker CV; Julian BA
Nephrol Dial Transplant; 2005 Jun; 20(6):1214-21. PubMed ID: 15797890
[TBL] [Abstract][Full Text] [Related]
16. IgA NEPHROPATHY IN PATIENTS RECEIVING A RENAL TRANSPLANT.
Lemes-Canuto AP; de Sandes-Freitas TV; Medina-Pestana JO; Mastroianni-Kirsztajn G
J Ren Care; 2015 Dec; 41(4):222-30. PubMed ID: 25819382
[TBL] [Abstract][Full Text] [Related]
17. Outcomes following Kidney transplantation in IgA nephropathy: a UNOS/OPTN analysis.
Kadiyala A; Mathew AT; Sachdeva M; Sison CP; Shah HH; Fishbane S; Jhaveri KD
Clin Transplant; 2015 Oct; 29(10):911-9. PubMed ID: 26190417
[TBL] [Abstract][Full Text] [Related]
18. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
19. Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol.
Ibrahim H; Rogers T; Casingal V; Sturdevant M; Tan M; Humar A; Gillingham K; Matas A
Transplantation; 2006 Jan; 81(2):214-9. PubMed ID: 16436965
[TBL] [Abstract][Full Text] [Related]
20. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy.
Bantis C; Heering PJ; Aker S; Schwandt C; Grabensee B; Ivens K
J Nephrol; 2008; 21(6):941-6. PubMed ID: 19034880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
